Correlation Between Mirum Pharmaceuticals and Kalvista Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mirum Pharmaceuticals and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mirum Pharmaceuticals and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mirum Pharmaceuticals and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Mirum Pharmaceuticals and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mirum Pharmaceuticals with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mirum Pharmaceuticals and Kalvista Pharmaceuticals.
Diversification Opportunities for Mirum Pharmaceuticals and Kalvista Pharmaceuticals
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mirum and Kalvista is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Mirum Pharmaceuticals and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Mirum Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mirum Pharmaceuticals are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Mirum Pharmaceuticals i.e., Mirum Pharmaceuticals and Kalvista Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mirum Pharmaceuticals and Kalvista Pharmaceuticals
Given the investment horizon of 90 days Mirum Pharmaceuticals is expected to generate 0.73 times more return on investment than Kalvista Pharmaceuticals. However, Mirum Pharmaceuticals is 1.37 times less risky than Kalvista Pharmaceuticals. It trades about 0.32 of its potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 3,846 in Mirum Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 776.00 from holding Mirum Pharmaceuticals or generate 20.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mirum Pharmaceuticals vs. Kalvista Pharmaceuticals
Performance |
| Timeline |
| Mirum Pharmaceuticals |
| Kalvista Pharmaceuticals |
Mirum Pharmaceuticals and Kalvista Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mirum Pharmaceuticals and Kalvista Pharmaceuticals
The main advantage of trading using opposite Mirum Pharmaceuticals and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mirum Pharmaceuticals position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.| Mirum Pharmaceuticals vs. Immunocore Holdings | Mirum Pharmaceuticals vs. Larimar Therapeutics | Mirum Pharmaceuticals vs. Kalvista Pharmaceuticals | Mirum Pharmaceuticals vs. Lyra Therapeutics |
| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |